Xeplion (Paliperidone Vials) 150 mg/1.5 ml

Xeplion (paliperidone) is an injectable antipsychotic medication used for schizophrenia and schizoaffective disorder management. This 150 mg/1.5 ml vial form provides extended-release therapy for consistent symptom control. Store at ambient temperature for convenience and stability.

Strength

150 mg/1.5 ml

Pack Size

Storage

Ambient

Manufacturer / TM Owner

JOHNSON AND JOHNSON

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Xeplion is primarily used to treat schizophrenia and schizoaffective disorder by helping regulate brain chemicals. It may also be prescribed for mood stabilization in bipolar disorder when oral medication isn't suitable. Patients often ask what is Xeplion used for, and it's important to note this medication helps manage symptoms rather than cure the underlying condition. The extended-release formula provides steady medication levels over time.

Side Effects

Many patients experience improved focus and reduced agitation within weeks of starting Xeplion therapy. Some report better sleep patterns and decreased mood swings as their treatment progresses. The medication works gradually, so noticeable effects may take time to develop. Individual responses vary, with some patients feeling more emotionally stable while others experience mild drowsiness initially.

Precautions & Warnings

Keep Xeplion vials at room temperature away from direct sunlight and moisture. Always check the expiration date before use and handle vials carefully to prevent breakage. Store in a secure location out of reach of children and pets. If accidental exposure occurs, contact a healthcare provider immediately. Never reuse or share injection equipment between patients.

Avoid Interactions

Alcohol may increase drowsiness when combined with Xeplion, so consumption should be limited. Certain medications like blood pressure drugs or sedatives can interact with paliperidone, potentially affecting its effectiveness. Always inform your healthcare provider about all prescription and over-the-counter medications you're taking. Some herbal supplements may also interact with this medication.

Frequently Asked Questions

Effects may appear gradually over several weeks as the medication builds up in your system.

Some patients experience drowsiness, so use caution until you know how the medication affects you.

Contact your healthcare provider for guidance rather than taking an extra dose.

Xeplion is specifically formulated as an injectable medication for extended release.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.